Search

Search Constraints

You searched for: Author/Creator Teulé, Alex

Search Results

1. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. Issue 1 (December 2015)

2. Assessment of ovarian reserve and reproductive outcomes in BRCA1 or BRCA2 mutation carriers. Issue 1 (27th November 2019)

3. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores. (28th July 2021)

4. Comprehensive analysis and ACMG‐based classification of CHEK2 variants in hereditary cancer patients. Issue 12 (14th October 2020)

5. ERCC3, a new ovarian cancer susceptibility gene?. (December 2020)

6. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Issue 1 (December 2016)

7. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification. Issue 9 (13th September 2019)

8. Mutational spectrum in a worldwide study of 29, 700 families with BRCA1 or BRCA2 mutations. Issue 5 (12th March 2018)

9. Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels. Issue 10 (15th April 2019)

10. Sunitinib and Evofosfamide (TH-302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial. (14th July 2021)